Skip to main content
All lobbying filings

CAPITOL COUNSEL LLC

Lobbying for LUNDBECK PHARMACEUTICALS LLC · Specialty and Central Nervous System Bio-pharmaceutical manufacturing.

 Filing 3rd Quarter - Report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 20, 2025
Income
$40,000.00
What the client paid this registrant for the period.
Client based in
Illinois

Official filing document

 Lobbyists on this filing 1
  • JOSEPH EANNELLO New on this filing
    Previously held: Legislative Dir., Rep. Kevin Yoder; Sr. Legislative Assist., Rep. Yoder; Legislative Asst., Rep. Yoder; Legislative Corresp., Rep. Yoder; Legislative Asst., Rep. Jerry Weller; Legislative Corresp., Rep. Jerry Weller; Staff Asst., Rep. Jerry Weller.

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 1
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
 Lobbying activity 2
Health Issues

Issues regarding Pill Penalty caused by the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including H.R./S._Modernizing and Ensuring PBM Accountability Act.

Medicare/Medicaid

Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including H.R./S._ Modernizing and Ensuring PBM Accountability Act and H.R./S._Lower Costs, More Transparency Act. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia. Orphan Drug Provisions included in HR.1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem